AMACR
| Alpha-methylacyl-CoA racemase | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||
| Symbols | AMACR ; RACE | ||||||||||
| External IDs | Template:OMIM5 Template:MGI HomoloGene: 7410 | ||||||||||
| |||||||||||
| Orthologs | |||||||||||
| Template:GNF Ortholog box | |||||||||||
| Species | Human | Mouse | |||||||||
| Entrez | n/a | n/a | |||||||||
| Ensembl | n/a | n/a | |||||||||
| UniProt | n/a | n/a | |||||||||
| RefSeq (mRNA) | n/a | n/a | |||||||||
| RefSeq (protein) | n/a | n/a | |||||||||
| Location (UCSC) | n/a | n/a | |||||||||
| PubMed search | n/a | n/a | |||||||||
|
WikiDoc Resources for AMACR |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on AMACR at Clinical Trials.gov Clinical Trials on AMACR at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on AMACR
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating AMACR Risk calculators and risk factors for AMACR
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Alpha-methylacyl-CoA racemase, also known as AMACR, is a human gene.[1]
The AMACR protein helps to metabolize certain fatty acids within the body. Several studies have suggested that AMACR can be used as a prostate cancer biomarker[2].
References
- ↑ "Entrez Gene: AMACR alpha-methylacyl-CoA racemase".
- ↑ Rubin MA, Bismar TA, Andren O, et al. Decreased {alpha}-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Cancer Epidemiol Biomarkers Prev 2005;14:1424–32
Further reading
- Jiang Z, Woda BA, Wu CL, Yang XJ (2004). "Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S)". Am. J. Clin. Pathol. 122 (2): 275–89. doi:10.1309/EJUY-UQPE-X1MG-68MK. PMID 15323145.
- Bautch S (1991). "Wisconsin doctor selected as national symbol of physicians' sacrifices". Wis. Med. J. 90 (8): 485–7. PMID 1926890.
- Schmitz W, Albers C, Fingerhut R, Conzelmann E (1995). "Purification and characterization of an alpha-methylacyl-CoA racemase from human liver". Eur. J. Biochem. 231 (3): 815–22. PMID 7649182.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
- Schmitz W, Helander HM, Hiltunen JK, Conzelmann E (1997). "Molecular cloning of cDNA species for rat and mouse liver alpha-methylacyl-CoA racemases". Biochem. J. 326 ( Pt 3): 883–9. PMID 9307041.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
- Ferdinandusse S, Denis S, Clayton PT; et al. (2000). "Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy". Nat. Genet. 24 (2): 188–91. doi:10.1038/72861. PMID 10655068.
- Kotti TJ, Savolainen K, Helander HM; et al. (2000). "In mouse alpha -methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes". J. Biol. Chem. 275 (27): 20887–95. doi:10.1074/jbc.M002067200. PMID 10770938.
- Amery L, Fransen M, De Nys K; et al. (2001). "Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans". J. Lipid Res. 41 (11): 1752–9. PMID 11060344.
- Hartley JL, Temple GF, Brasch MA (2001). "DNA cloning using in vitro site-specific recombination". Genome Res. 10 (11): 1788–95. PMID 11076863.
- Rubin MA, Zhou M, Dhanasekaran SM; et al. (2002). "alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer". JAMA. 287 (13): 1662–70. PMID 11926890.
- Luo J, Zha S, Gage WR; et al. (2002). "Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer". Cancer Res. 62 (8): 2220–6. PMID 11956072.
- Zhou M, Chinnaiyan AM, Kleer CG; et al. (2002). "Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions". Am. J. Surg. Pathol. 26 (7): 926–31. PMID 12131161.
- Kuefer R, Varambally S, Zhou M; et al. (2002). "alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation". Am. J. Pathol. 161 (3): 841–8. PMID 12213712.
- Varambally S, Dhanasekaran SM, Zhou M; et al. (2002). "The polycomb group protein EZH2 is involved in progression of prostate cancer". Nature. 419 (6907): 624–9. doi:10.1038/nature01075. PMID 12374981.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Leav I, McNeal JE, Ho SM, Jiang Z (2003). "Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone". Hum. Pathol. 34 (3): 228–33. doi:10.1053/hupa.2003.42. PMID 12673556.
- Shen-Ong GL, Feng Y, Troyer DA (2003). "Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology". Cancer Res. 63 (12): 3296–301. PMID 12810662.
- Zha S, Ferdinandusse S, Denis S; et al. (2004). "Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer". Cancer Res. 63 (21): 7365–76. PMID 14612535.
- Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.